IBDEI0AG ; ; 13-FEB-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 13, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,13849,0)
 ;;=428.0^^89^815^8
 ;;^UTILITY(U,$J,358.3,13849,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13849,1,3,0)
 ;;=3^428.0
 ;;^UTILITY(U,$J,358.3,13849,1,4,0)
 ;;=4^CHF
 ;;^UTILITY(U,$J,358.3,13849,2)
 ;;=^54758
 ;;^UTILITY(U,$J,358.3,13850,0)
 ;;=414.9^^89^815^10
 ;;^UTILITY(U,$J,358.3,13850,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13850,1,3,0)
 ;;=3^414.9
 ;;^UTILITY(U,$J,358.3,13850,1,4,0)
 ;;=4^ISCHEMIC HEART DIS, CHRONIC
 ;;^UTILITY(U,$J,358.3,13850,2)
 ;;=^24401
 ;;^UTILITY(U,$J,358.3,13851,0)
 ;;=394.9^^89^815^12
 ;;^UTILITY(U,$J,358.3,13851,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13851,1,3,0)
 ;;=3^394.9
 ;;^UTILITY(U,$J,358.3,13851,1,4,0)
 ;;=4^MITRAL VALVE DISEASE
 ;;^UTILITY(U,$J,358.3,13851,2)
 ;;=^269571
 ;;^UTILITY(U,$J,358.3,13852,0)
 ;;=443.9^^89^815^13
 ;;^UTILITY(U,$J,358.3,13852,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13852,1,3,0)
 ;;=3^443.9
 ;;^UTILITY(U,$J,358.3,13852,1,4,0)
 ;;=4^PERIPH VASCULAR DIS
 ;;^UTILITY(U,$J,358.3,13852,2)
 ;;=^184182
 ;;^UTILITY(U,$J,358.3,13853,0)
 ;;=424.1^^89^815^3
 ;;^UTILITY(U,$J,358.3,13853,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13853,1,3,0)
 ;;=3^424.1
 ;;^UTILITY(U,$J,358.3,13853,1,4,0)
 ;;=4^AORTIC VALVE DIS
 ;;^UTILITY(U,$J,358.3,13853,2)
 ;;=^9330
 ;;^UTILITY(U,$J,358.3,13854,0)
 ;;=459.81^^89^815^14
 ;;^UTILITY(U,$J,358.3,13854,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13854,1,3,0)
 ;;=3^459.81
 ;;^UTILITY(U,$J,358.3,13854,1,4,0)
 ;;=4^VENOUS INSUFFICIENCY
 ;;^UTILITY(U,$J,358.3,13854,2)
 ;;=^125826
 ;;^UTILITY(U,$J,358.3,13855,0)
 ;;=411.1^^89^815^2
 ;;^UTILITY(U,$J,358.3,13855,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13855,1,3,0)
 ;;=3^411.1
 ;;^UTILITY(U,$J,358.3,13855,1,4,0)
 ;;=4^ANGINA PECTORIS/UNSTABLE
 ;;^UTILITY(U,$J,358.3,13855,2)
 ;;=^7455
 ;;^UTILITY(U,$J,358.3,13856,0)
 ;;=429.2^^89^815^4
 ;;^UTILITY(U,$J,358.3,13856,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13856,1,3,0)
 ;;=3^429.2
 ;;^UTILITY(U,$J,358.3,13856,1,4,0)
 ;;=4^ASCVD
 ;;^UTILITY(U,$J,358.3,13856,2)
 ;;=^19738
 ;;^UTILITY(U,$J,358.3,13857,0)
 ;;=414.01^^89^815^6
 ;;^UTILITY(U,$J,358.3,13857,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13857,1,3,0)
 ;;=3^414.01
 ;;^UTILITY(U,$J,358.3,13857,1,4,0)
 ;;=4^CAD
 ;;^UTILITY(U,$J,358.3,13857,2)
 ;;=^303281
 ;;^UTILITY(U,$J,358.3,13858,0)
 ;;=401.9^^89^815^9
 ;;^UTILITY(U,$J,358.3,13858,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13858,1,3,0)
 ;;=3^401.9
 ;;^UTILITY(U,$J,358.3,13858,1,4,0)
 ;;=4^HYPERTENSION, ESSENTIAL
 ;;^UTILITY(U,$J,358.3,13858,2)
 ;;=^186630
 ;;^UTILITY(U,$J,358.3,13859,0)
 ;;=394.0^^89^815^11
 ;;^UTILITY(U,$J,358.3,13859,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13859,1,3,0)
 ;;=3^394.0
 ;;^UTILITY(U,$J,358.3,13859,1,4,0)
 ;;=4^MITRAL STENOSIS
 ;;^UTILITY(U,$J,358.3,13859,2)
 ;;=^78404
 ;;^UTILITY(U,$J,358.3,13860,0)
 ;;=285.9^^89^816^1
 ;;^UTILITY(U,$J,358.3,13860,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13860,1,3,0)
 ;;=3^285.9
 ;;^UTILITY(U,$J,358.3,13860,1,4,0)
 ;;=4^ANEMIA
 ;;^UTILITY(U,$J,358.3,13860,2)
 ;;=^7007
 ;;^UTILITY(U,$J,358.3,13861,0)
 ;;=266.2^^89^816^2
 ;;^UTILITY(U,$J,358.3,13861,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13861,1,3,0)
 ;;=3^266.2
 ;;^UTILITY(U,$J,358.3,13861,1,4,0)
 ;;=4^B12 & FOLATE ANEMIA
 ;;^UTILITY(U,$J,358.3,13861,2)
 ;;=^87347
 ;;^UTILITY(U,$J,358.3,13862,0)
 ;;=272.0^^89^816^3
 ;;^UTILITY(U,$J,358.3,13862,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13862,1,3,0)
 ;;=3^272.0
 ;;^UTILITY(U,$J,358.3,13862,1,4,0)
 ;;=4^CHOLESTEROL (HYPER)
 ;;^UTILITY(U,$J,358.3,13862,2)
 ;;=^59973
 ;;^UTILITY(U,$J,358.3,13863,0)
 ;;=250.00^^89^816^6
 ;;^UTILITY(U,$J,358.3,13863,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13863,1,3,0)
 ;;=3^250.00
 ;;^UTILITY(U,$J,358.3,13863,1,4,0)
 ;;=4^DIABETES MEL W/O COMP, TYPE II
 ;;^UTILITY(U,$J,358.3,13863,2)
 ;;=^33605
 ;;^UTILITY(U,$J,358.3,13864,0)
 ;;=250.02^^89^816^5
 ;;^UTILITY(U,$J,358.3,13864,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13864,1,3,0)
 ;;=3^250.02
 ;;^UTILITY(U,$J,358.3,13864,1,4,0)
 ;;=4^DIAB MEL W/O COMP, TYPE II UNCONT
 ;;^UTILITY(U,$J,358.3,13864,2)
 ;;=^295704
 ;;^UTILITY(U,$J,358.3,13865,0)
 ;;=272.4^^89^816^9
 ;;^UTILITY(U,$J,358.3,13865,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13865,1,3,0)
 ;;=3^272.4
 ;;^UTILITY(U,$J,358.3,13865,1,4,0)
 ;;=4^HYPERLIPIDEMIA
 ;;^UTILITY(U,$J,358.3,13865,2)
 ;;=^87281
 ;;^UTILITY(U,$J,358.3,13866,0)
 ;;=244.9^^89^816^10
 ;;^UTILITY(U,$J,358.3,13866,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13866,1,3,0)
 ;;=3^244.9
 ;;^UTILITY(U,$J,358.3,13866,1,4,0)
 ;;=4^HYPOTHYROIDISM
 ;;^UTILITY(U,$J,358.3,13866,2)
 ;;=^123752
 ;;^UTILITY(U,$J,358.3,13867,0)
 ;;=250.01^^89^816^4
 ;;^UTILITY(U,$J,358.3,13867,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13867,1,3,0)
 ;;=3^250.01
 ;;^UTILITY(U,$J,358.3,13867,1,4,0)
 ;;=4^DIAB MEL W/O COMP, TYPE I
 ;;^UTILITY(U,$J,358.3,13867,2)
 ;;=^33586
 ;;^UTILITY(U,$J,358.3,13868,0)
 ;;=278.01^^89^816^11
 ;;^UTILITY(U,$J,358.3,13868,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13868,1,3,0)
 ;;=3^278.01
 ;;^UTILITY(U,$J,358.3,13868,1,4,0)
 ;;=4^OBESITY, MORBID
 ;;^UTILITY(U,$J,358.3,13868,2)
 ;;=^84844
 ;;^UTILITY(U,$J,358.3,13869,0)
 ;;=286.59^^89^816^7
 ;;^UTILITY(U,$J,358.3,13869,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13869,1,3,0)
 ;;=3^286.59
 ;;^UTILITY(U,$J,358.3,13869,1,4,0)
 ;;=4^HEMOR D/O DUE TO CIRC ANTICOAG
 ;;^UTILITY(U,$J,358.3,13869,2)
 ;;=^340504
 ;;^UTILITY(U,$J,358.3,13870,0)
 ;;=268.9^^89^816^12
 ;;^UTILITY(U,$J,358.3,13870,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13870,1,3,0)
 ;;=3^268.9
 ;;^UTILITY(U,$J,358.3,13870,1,4,0)
 ;;=4^VITAMIN D DEFICIENCY NOS
 ;;^UTILITY(U,$J,358.3,13870,2)
 ;;=^126968
 ;;^UTILITY(U,$J,358.3,13871,0)
 ;;=790.29^^89^816^8
 ;;^UTILITY(U,$J,358.3,13871,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13871,1,3,0)
 ;;=3^790.29
 ;;^UTILITY(U,$J,358.3,13871,1,4,0)
 ;;=4^HYPERGLYCEMIA
 ;;^UTILITY(U,$J,358.3,13871,2)
 ;;=^329955
 ;;^UTILITY(U,$J,358.3,13872,0)
 ;;=389.9^^89^817^7
 ;;^UTILITY(U,$J,358.3,13872,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13872,1,3,0)
 ;;=3^389.9
 ;;^UTILITY(U,$J,358.3,13872,1,4,0)
 ;;=4^HEARING LOSS
 ;;^UTILITY(U,$J,358.3,13872,2)
 ;;=^54552
 ;;^UTILITY(U,$J,358.3,13873,0)
 ;;=380.4^^89^817^8
 ;;^UTILITY(U,$J,358.3,13873,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13873,1,3,0)
 ;;=3^380.4
 ;;^UTILITY(U,$J,358.3,13873,1,4,0)
 ;;=4^IMPACTED CERUMEN
 ;;^UTILITY(U,$J,358.3,13873,2)
 ;;=^62061
 ;;^UTILITY(U,$J,358.3,13874,0)
 ;;=382.9^^89^817^9
 ;;^UTILITY(U,$J,358.3,13874,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13874,1,3,0)
 ;;=3^382.9
 ;;^UTILITY(U,$J,358.3,13874,1,4,0)
 ;;=4^OTITIS MEDIA
 ;;^UTILITY(U,$J,358.3,13874,2)
 ;;=^123967
 ;;^UTILITY(U,$J,358.3,13875,0)
 ;;=365.11^^89^817^5
 ;;^UTILITY(U,$J,358.3,13875,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13875,1,3,0)
 ;;=3^365.11
 ;;^UTILITY(U,$J,358.3,13875,1,4,0)
 ;;=4^GLAUCOMA,PRIMARY OPEN ANGLE
 ;;^UTILITY(U,$J,358.3,13875,2)
 ;;=^51203
 ;;^UTILITY(U,$J,358.3,13876,0)
 ;;=372.72^^89^817^10
 ;;^UTILITY(U,$J,358.3,13876,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13876,1,3,0)
 ;;=3^372.72
 ;;^UTILITY(U,$J,358.3,13876,1,4,0)
 ;;=4^SUBCONJUNCTIVAL HEMORRHAGE
 ;;^UTILITY(U,$J,358.3,13876,2)
 ;;=^27538
 ;;^UTILITY(U,$J,358.3,13877,0)
 ;;=365.70^^89^817^1
 ;;^UTILITY(U,$J,358.3,13877,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13877,1,3,0)
 ;;=3^365.70
 ;;^UTILITY(U,$J,358.3,13877,1,4,0)
 ;;=4^GLAUCOMA STAGE NOS
 ;;^UTILITY(U,$J,358.3,13877,2)
 ;;=^340609
 ;;^UTILITY(U,$J,358.3,13878,0)
 ;;=365.71^^89^817^3
 ;;^UTILITY(U,$J,358.3,13878,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13878,1,3,0)
 ;;=3^365.71
 ;;^UTILITY(U,$J,358.3,13878,1,4,0)
 ;;=4^GLAUCOMA,MILD STAGE
 ;;^UTILITY(U,$J,358.3,13878,2)
 ;;=^340513
 ;;^UTILITY(U,$J,358.3,13879,0)
 ;;=365.72^^89^817^4
 ;;^UTILITY(U,$J,358.3,13879,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13879,1,3,0)
 ;;=3^365.72
 ;;^UTILITY(U,$J,358.3,13879,1,4,0)
 ;;=4^GLAUCOMA,MODERATE STAGE
 ;;^UTILITY(U,$J,358.3,13879,2)
 ;;=^340514
 ;;^UTILITY(U,$J,358.3,13880,0)
 ;;=365.73^^89^817^6
 ;;^UTILITY(U,$J,358.3,13880,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13880,1,3,0)
 ;;=3^365.73
 ;;^UTILITY(U,$J,358.3,13880,1,4,0)
 ;;=4^GLAUCOMA,SEVERE STAGE
 ;;^UTILITY(U,$J,358.3,13880,2)
 ;;=^340515
 ;;^UTILITY(U,$J,358.3,13881,0)
 ;;=365.74^^89^817^2
 ;;^UTILITY(U,$J,358.3,13881,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13881,1,3,0)
 ;;=3^365.74
 ;;^UTILITY(U,$J,358.3,13881,1,4,0)
 ;;=4^GLAUCOMA,INDETERM STAGE
 ;;^UTILITY(U,$J,358.3,13881,2)
 ;;=^340516
 ;;^UTILITY(U,$J,358.3,13882,0)
 ;;=571.5^^89^818^1
 ;;^UTILITY(U,$J,358.3,13882,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13882,1,3,0)
 ;;=3^571.5
 ;;^UTILITY(U,$J,358.3,13882,1,4,0)
 ;;=4^CIRRHOSIS OF LIVER
 ;;^UTILITY(U,$J,358.3,13882,2)
 ;;=^24731
 ;;^UTILITY(U,$J,358.3,13883,0)
 ;;=530.81^^89^818^2
 ;;^UTILITY(U,$J,358.3,13883,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13883,1,3,0)
 ;;=3^530.81
 ;;^UTILITY(U,$J,358.3,13883,1,4,0)
 ;;=4^ESOPHAGEAL REFLUX (GERD)
 ;;^UTILITY(U,$J,358.3,13883,2)
 ;;=^295749
 ;;^UTILITY(U,$J,358.3,13884,0)
 ;;=558.9^^89^818^4
 ;;^UTILITY(U,$J,358.3,13884,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13884,1,3,0)
 ;;=3^558.9
 ;;^UTILITY(U,$J,358.3,13884,1,4,0)
 ;;=4^GASTROENTERITIS/COLITIS, NONINFECT
 ;;^UTILITY(U,$J,358.3,13884,2)
 ;;=^87311
 ;;^UTILITY(U,$J,358.3,13885,0)
 ;;=564.1^^89^818^8
 ;;^UTILITY(U,$J,358.3,13885,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13885,1,3,0)
 ;;=3^564.1
 ;;^UTILITY(U,$J,358.3,13885,1,4,0)
 ;;=4^IRRITABLE COLON
 ;;^UTILITY(U,$J,358.3,13885,2)
 ;;=^65682
 ;;^UTILITY(U,$J,358.3,13886,0)
 ;;=211.3^^89^818^9
 ;;^UTILITY(U,$J,358.3,13886,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13886,1,3,0)
 ;;=3^211.3
 ;;^UTILITY(U,$J,358.3,13886,1,4,0)
 ;;=4^POLYPS, COLON/LG BOWEL (BENIGN NEO
 ;;^UTILITY(U,$J,358.3,13886,2)
 ;;=^13295
